Novavax | Passività Correnti

Current Liabilities Cambiamento Data
Adma Biologics USD 49.81M 7.96M 2023-12
AstraZeneca USD 28.59B 2.21B 2023-09
Cassava Sciences USD 17.41M 481K 2023-09
Dynavax Technologies USD 62.2M 7.93M 2023-12
Geron USD 108.07M 18.68M 2023-12
GlaxoSmithKline GBP 22.39B 282M 2023-09
MannKind USD 104.12M 7.75M 2023-12
Merck USD 23.09B 300M 2023-09
Moderna USD 3.02B 1.37B 2023-12
Pfizer USD 31.14B 3.51B 2023-09
Sarepta Therapeutics USD 450.74M 47.91M 2023-09
TG Therapeutics USD 57.68M 14.99M 2023-09



Novavax Passività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2024.